Literature DB >> 9864143

CC chemokine receptors, CCR-1 and CCR-3, are potentially involved in antigen-presenting cell function of human peripheral blood monocyte-derived dendritic cells.

K Sato1, H Kawasaki, H Nagayama, R Serizawa, J Ikeda, C Morimoto, K Yasunaga, N Yamaji, K Tadokoro, T Juji, T A Takahashi.   

Abstract

We examined the potential involvement of two CC chemokine receptors (CCRs), CCR-1 and CCR-3, in the functional activation of granulocyte-macrophage colony-stimulating factor (GM-CSF) plus interleukin-4 (IL-4)-generated human peripheral blood monocyte-derived immature dendritic cells (DCs). Flow cytometric analysis showed that CCR-1, CCR-3, CCR-5, and CXC chemokine receptor (CXCR)-4 were expressed on the cell surface of monocyte-derived DCs. Treatment with a monoclonal antibody (MoAb) to either CCR-1 or CCR-3 but not MoAbs to CCR-5 and CXCR-4 abolished chemotactic migration of monocyte-derived DCs. The DCs treated with either the anti-CCR-1 MoAb or anti-CCR-3 MoAb were less efficient than untreated DCs in proliferation of allogeneic T cells (TCs) and TC-derived secretion of interferon-gamma (IFN-gamma). The homotypic aggregation of DCs and heterotypic aggregation of DCs with TCs were suppressed by the anti-CCR-1 MoAb or anti-CCR-3 MoAb. These results indicate that CCR-1 and CCR-3 specifically regulate interaction of TCs and DCs in the process of antigen presentation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9864143

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  Chemokines and dendritic cell traffic.

Authors:  S Sozzani; P Allavena; A Vecchi; A Mantovani
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

Review 2.  The specialized roles of immature and mature dendritic cells in antigen cross-presentation.

Authors:  Richard A Hopkins; John E Connolly
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

3.  Leishmania infection impairs beta 1-integrin function and chemokine receptor expression in mononuclear phagocytes.

Authors:  Nathanael F Pinheiro; Micely D R Hermida; Mariana P Macedo; José Mengel; Andre Bafica; Washington L C dos-Santos
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 4.  Chemokine and chemotactic signals in dendritic cell migration.

Authors:  Laura Tiberio; Annalisa Del Prete; Tiziana Schioppa; Francesca Sozio; Daniela Bosisio; Silvano Sozzani
Journal:  Cell Mol Immunol       Date:  2018-03-21       Impact factor: 11.530

5.  CCR2 plays a critical role in dendritic cell maturation: possible role of CCL2 and NF-kappa B.

Authors:  Fabio Jimenez; Marlon P Quinones; Hernan G Martinez; Carlos A Estrada; Kassandra Clark; Edgar Garavito; Jessica Ibarra; Peter C Melby; Seema S Ahuja
Journal:  J Immunol       Date:  2010-04-19       Impact factor: 5.422

6.  Deletion of the chemokine receptor CCR1 prolongs corneal allograft survival.

Authors:  Pedram Hamrah; Satoru Yamagami; Ying Liu; Qiang Zhang; Sudhir S Vora; Bao Lu; Craig J Gerard; M Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-03       Impact factor: 4.799

7.  Yersinia enterocolitica invasin protein triggers differential production of interleukin-1, interleukin-8, monocyte chemoattractant protein 1, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor alpha in epithelial cells: implications for understanding the early cytokine network in Yersinia infections.

Authors:  D Kampik; R Schulte; I B Autenrieth
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

Review 8.  Role of G protein-coupled receptors in control of dendritic cell migration.

Authors:  Yuan Liu; Guixiu Shi
Journal:  Biomed Res Int       Date:  2014-03-10       Impact factor: 3.411

9.  The Chemokine Receptor CXCR4 Mediates Recruitment of CD11c+ Conventional Dendritic Cells Into the Inflamed Murine Cornea.

Authors:  Maria J Lopez; Yashar Seyed-Razavi; Arsia Jamali; Deshea L Harris; Pedram Hamrah
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-11-01       Impact factor: 4.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.